Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS

被引:61
作者
Iannello, Alexandre
Debbeche, Olfa
Samarani, Suzanne
Ahmad, Ali [1 ]
机构
[1] Ste Justine Hosp, Res Ctr, Lab Innate Immun, Montreal, PQ H3T 1C5, Canada
关键词
CD94/NKG2; chemokines; cytokines; HIV-1; HLA; KIR; KIR haplotypes; MHC class I; MICA; MICB; NKG2D; ULBP;
D O I
10.1189/jlb.0907650
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
NK cells play an important role in controlling viral infections. They can kill virus-infected cells directly as well as indirectly via antibody-dependent, cell-mediated cytotoxicity. They need no prior sensitization and expansion for this killing. NK cells are also considered as important regulators of antiviral immune responses. They do so by secreting a multitude of soluble mediators and by directly interacting with other immune cells, e. g., dendritic cells. NK cells do not possess a single well-defined receptor to recognize antigens on target cells. Instead, they express an array of inhibitory and activating receptors and coreceptors, which bind to their cognate ligands expressed on the surface of target cells. These ligands include classical and nonclassical MHC class I antigens, MHC-like proteins, and a variety of other self-and virus-derived molecules. They may be expressed constitutively and/or de novo on the surface of virus-infected cells. NK cell receptors (NKRs) of the killer-cell Ig-like receptor (KIR) family, like their MHC class I ligands, are highly polymorphic. Several recent studies suggest that epistatic interactions between certain KIR and MHC class I genes may determine innate resistance of the host to viral infections, including HIV. In the first part of this review article, we provide an overview of the current state of knowledge of NK cell immunobiology and describe how NKR genes, alone and in combination with HLA genes, may determine genetic resistance/susceptibilty to HIV infection and the development of AIDS in humans.
引用
收藏
页码:1 / 26
页数:26
相关论文
共 193 条
[11]   The mechanisms controlling the recognition of tumor- and virus-infected cells by NKp46 [J].
Arnon, TI ;
Achdout, H ;
Lieberman, N ;
Gazit, R ;
Gonen-Gross, T ;
Katz, G ;
Bar-Ilan, A ;
Bloushtain, N ;
Lev, M ;
Joseph, A ;
Kedar, E ;
Porgador, A ;
Mandelboim, O .
BLOOD, 2004, 103 (02) :664-672
[12]   Natural killer cell and macrophage cooperation in MyD88-dependent innate responses to Plasmodium falciparum [J].
Baratin, M ;
Roetynck, S ;
Lépolard, C ;
Falk, C ;
Sawadogo, S ;
Uematsu, S ;
Akira, S ;
Ryffel, B ;
Tiraby, JG ;
Alexopoulou, L ;
Kirschning, CJ ;
Gysin, J ;
Vivier, E ;
Ugolini, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (41) :14747-14752
[13]   LFA-1 contributes an early signal for NK cell cytotoxicity [J].
Barber, DF ;
Faure, M ;
Long, EO .
JOURNAL OF IMMUNOLOGY, 2004, 173 (06) :3653-3659
[14]   Synergy or independence? Deciphering the interaction of HLA class I and NK cell KIR alleles in early HIV-1 disease progression [J].
Barbour, Jason D. ;
Sriram, Uma ;
Caillier, Stacy J. ;
Levy, Jay A. ;
Hecht, Frederick M. ;
Oksenberg, Jorge R. .
PLOS PATHOGENS, 2007, 3 (04) :471-474
[15]   The killer immunoglobulin-like receptor gene cluster: Tuning the genome for defense [J].
Bashirova, Arman A. ;
Martin, Maureen P. ;
McVicar, Daniel W. ;
Carrington, Mary .
ANNUAL REVIEW OF GENOMICS AND HUMAN GENETICS, 2006, 7 :277-300
[16]   Activation of NK Cells and T Cells by NKG2D, a Receptor for Stress-Inducible MICA [J].
Bauer, Stefan ;
Groh, Veronika ;
Wu, Jun ;
Steinle, Alexander ;
Phillips, Joseph H. ;
Lanier, Lewis L. ;
Spies, Thomas .
JOURNAL OF IMMUNOLOGY, 2018, 200 (07) :2231-2233
[17]   The biology of NKT cells [J].
Bendelac, Albert ;
Savage, Paul B. ;
Teyton, Luc .
ANNUAL REVIEW OF IMMUNOLOGY, 2007, 25 :297-336
[18]   Cutting edge: Defective NK cell activation in X-linked lymphoproliferative disease [J].
Benoit, L ;
Wang, XX ;
Pabst, HF ;
Dutz, J ;
Tan, R .
JOURNAL OF IMMUNOLOGY, 2000, 165 (07) :3549-3553
[19]  
Berman ME, 1996, J IMMUNOL, V156, P1515
[20]  
Bertone S, 1999, EUR J IMMUNOL, V29, P23, DOI 10.1002/(SICI)1521-4141(199901)29:01<23::AID-IMMU23>3.0.CO